The experience of treating patients with acute myocardial infarction under the COVID‐19 epidemic
Open Access
- 29 April 2020
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 97 (2), E244-E248
- https://doi.org/10.1002/ccd.28951
Abstract
Worldwide Coronavirus Disease 2019 (COVID‐19) epidemic makes the management of acute myocardial infarction (AMI) more complicated, effective treatment without further dissemination is thus quite challenging. Recently, we successfully treated three representative AMI cases, by sharing these detailed procedures, we summarized some important issues including patient screening, reperfusion strategy selecting, personnel/catheter lab protection principle, as well as operation tactics, which may lend precious experience on AMI treating during the ongoing COVID‐19 pandemic situation.Keywords
This publication has 7 references indexed in Scilit:
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaThe New England Journal of Medicine, 2020
- [Expert consensus on principal of clinical management of patients with severe emergent cardiovascular diseases during the epidemic period of COVID-19].2020
- Transmission of 2019-nCoV Infection from an Asymptomatic Contact in GermanyThe New England Journal of Medicine, 2020
- Asymptomatic cases in a family cluster with SARS-CoV-2 infectionThe Lancet Infectious Diseases, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- [2019 Chinese Society of Cardiology (CSC) guidelines for the diagnosis and management of patients with ST-segment elevation myocardial infarction].2019
- 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial InfarctionJournal of the American College of Cardiology, 2017